Filing Details
- Accession Number:
- 0001209191-21-033360
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-17 21:37:43
- Reporting Period:
- 2021-05-14
- Accepted Time:
- 2021-05-17 21:37:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082038 | Durect Corp | DRRX | Pharmaceutical Preparations (2834) | 943297098 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604753 | R Judy Joice | C/O Durect Corporation 10260 Bubb Road Cupertino CA 95014 | Sr. Vp Operations & Corp Qa | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-14 | 20,000 | $0.73 | 54,832 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-14 | 40,137 | $0.78 | 94,969 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-14 | 60,137 | $1.72 | 34,832 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-05-14 | 20,000 | $0.00 | 20,000 | $0.73 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-05-14 | 40,137 | $0.00 | 40,137 | $0.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-04-11 | No | 4 | M | Direct | |
| 0 | 2022-02-03 | No | 4 | M | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions. Prices ranged from $1.70 to $1.725 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Number of shares beneficially owned which were acquired by the Reporting Person under Durect's Employee Stock Purchase Plan between 11/01/2007 to 05/14/2021.
- The option is fully vested.
Billionaire Hedge Funds
